Invesco’s Kindred Biosciences KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-98,312
Closed -$1.08M – 3889
2018
Q4
$1.08M Sell
98,312
-98,910
-50% -$1.25M ﹤0.01% 2930
2018
Q3
$2.75M Buy
+197,222
New +$2.67M ﹤0.01% 2541

Other funds holding KIN

Invesco's KIN Position: Q1 2019 in Review

Invesco sold out of Kindred Biosciences (KIN) in Q1 2019, closing a stake of 98,312 shares — an estimated $1.08M sold.

Invesco first reported a position in KIN in Q3 2018 and held it in 2 quarters. The position peaked at $2.75M in Q3 2018. 75 funds tracked by Wall St. Rank hold KIN as of Q1 2019.

  • Invesco reported no remaining Kindred Biosciences position as of Q1 2019 after selling out during the quarter.
  • Invesco sold 98,312 Kindred Biosciences shares in Q1 2019, an estimated $1.08M.
  • Invesco first reported a position in Kindred Biosciences in Q3 2018 and held it in 2 quarters.
  • Invesco's Kindred Biosciences position peaked at $2.75M in Q3 2018.
  • 75 funds tracked by Wall St. Rank held Kindred Biosciences as of Q1 2019.

Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.